JORDAN SPARROW: Open Payments
NPI 1457968521 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,580 in 76 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $810 · 2025 $1,580
Food & beverage: $1,580
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 1 | $243 |
| Amgen Inc. | 11 | $205 |
| Regeneron Healthcare Solutions, Inc. | 7 | $172 |
| UCB, Inc. | 13 | $149 |
| Galderma Laboratories, L.P. | 14 | $143 |
| REVANCE THERAPEUTICS, INC. | 1 | $103 |
| GENZYME CORPORATION | 4 | $102 |
| Lilly USA, LLC | 4 | $80 |
| Organon LLC | 4 | $74 |
| PFIZER INC. | 4 | $65 |
Products named: DUPIXENT, Zoryve, OTEZLA, Bimzelx, DAXXIFY, NEMLUVIO, TALTZ, CIBINQO.
Industry payments across AR — which companies pay providers there.
